Growth Metrics

Boston Scientific (BSX) Share-based Compensation (2016 - 2026)

Boston Scientific's Share-based Compensation history spans 18 years, with the latest figure at $83.0 million for Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 12.16% to $83.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $308.0 million, a 11.19% increase, with the full-year FY2025 number at $299.0 million, up 12.41% from a year prior.
  • Share-based Compensation hit $83.0 million in Q1 2026 for Boston Scientific, up from $71.0 million in the prior quarter.
  • Over the last five years, Share-based Compensation for BSX hit a ceiling of $83.0 million in Q1 2026 and a floor of $52.0 million in Q1 2022.
  • Historically, Share-based Compensation has averaged $64.8 million across 5 years, with a median of $63.0 million in 2024.
  • Biggest five-year swings in Share-based Compensation: rose 1.72% in 2023 and later grew 17.46% in 2025.
  • Tracing BSX's Share-based Compensation over 5 years: stood at $55.0 million in 2022, then grew by 7.27% to $59.0 million in 2023, then increased by 16.95% to $69.0 million in 2024, then rose by 2.9% to $71.0 million in 2025, then increased by 16.9% to $83.0 million in 2026.
  • Business Quant data shows Share-based Compensation for BSX at $83.0 million in Q1 2026, $71.0 million in Q4 2025, and $79.0 million in Q3 2025.